Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

KMTS - Kestra Medical Technologies, Ltd.... | Finranks

Home

KMTS

(KMTS)

NMS – Real vaqt narxi. Valyuta: USD

19.46

-0.22 (-1.12%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

19.46

0.00 (0.00%)

Bozordan keyin: Mar 27, 2026, 4:34 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”

Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”

KIRKLAND, Wash., March 25, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a finalist in the “Deal of the Year” category for the 2026 GeekWire Awards. Now in its 15th year, the annual awards recognize companies and leaders shaping the Pacific Northwest technology ecosystem, where Kestra continues to expand its presence.

Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript

Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript

Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript

Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results

Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results

KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the third quarter fiscal 2026, which ended January 31, 2026.

Kestra Medical Technologies to Report Third Quarter Fiscal 2026 Financial Results on March 17

Kestra Medical Technologies to Report Third Quarter Fiscal 2026 Financial Results on March 17

KIRKLAND, Wash., March 03, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it will report third quarter fiscal 2026 financial results on Tuesday, March 17. Management will host a corresponding conference call at 4:30 p.m. Eastern Time.

KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery

KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery

Kestra teams up with Biobeat in an exclusive deal, investing $5M to add continuous blood pressure monitoring to the ASSURE WCD during cardiac recovery.

Kestra Medical Technologies, Ltd. (KMTS) Presents at 44th Annual J.P.

Kestra Medical Technologies, Ltd. (KMTS) Presents at 44th Annual J.P.

Kestra Medical Technologies, Ltd. (KMTS) Presents at 44th Annual J.P.

Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery

Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery

KIRKLAND, Wash., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.

Videolar

No Data

There is no data to display